Advertisement

Topics

Interview: Setting The Course For Takeda’s R&D Future

21:07 EDT 29 Jun 2017 | SCRIP

Dr. Andrew Plump joined Takeda from Sanofi in 2015 as the Japanese company's chief medical and scientific officer. In his...

      

Related Stories

 

Original Article: Interview: Setting The Course For Takeda’s R&D Future

NEXT ARTICLE

More From BioPortfolio on "Interview: Setting The Course For Takeda’s R&D Future"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Sanofi-Aventis
Sanofi-Aventis is a global pharmaceutical company with annual sales of $40,871m, placing it the second highest in the world. Although Sanofi-Aventis products are for a a very wide range of health problems, their major products are those for diabetes, o...